Correction to: Biologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology - what we know and what we do not know from randomized controlled trials
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Book |
| Published: |
BMC,
2021-08-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_c5d3d97aa11d4fd8936da38c4e388be9 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Tatjana Welzel |e author |
| 700 | 1 | 0 | |a Carolyn Winskill |e author |
| 700 | 1 | 0 | |a Nancy Zhang |e author |
| 700 | 1 | 0 | |a Andreas Woerner |e author |
| 700 | 1 | 0 | |a Marc Pfister |e author |
| 245 | 0 | 0 | |a Correction to: Biologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology - what we know and what we do not know from randomized controlled trials |
| 260 | |b BMC, |c 2021-08-01T00:00:00Z. | ||
| 500 | |a 10.1186/s12969-021-00593-3 | ||
| 500 | |a 1546-0096 | ||
| 546 | |a EN | ||
| 690 | |a Pediatrics | ||
| 690 | |a RJ1-570 | ||
| 690 | |a Diseases of the musculoskeletal system | ||
| 690 | |a RC925-935 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Pediatric Rheumatology Online Journal, Vol 19, Iss 1, Pp 1-1 (2021) | |
| 787 | 0 | |n https://doi.org/10.1186/s12969-021-00593-3 | |
| 787 | 0 | |n https://doaj.org/toc/1546-0096 | |
| 856 | 4 | 1 | |u https://doaj.org/article/c5d3d97aa11d4fd8936da38c4e388be9 |z Connect to this object online. |